Abbott Laboratories (ABT) Cash from Operations (2009 - 2026)

Abbott Laboratories has disclosed Cash from Operations across 18 years of filings, most recently posting 1315000000.0 for Q1 2026.

• Cash from Operations for Q1 2026 came in at 1315000000.0, down 7.2% year-over-year; the trailing twelve-month figure through Mar 2026 was 9464000000.0 (up 5.74% YoY), and the FY2025 annual result was 9566000000.0, up 11.78% from the prior year.
• Cash from Operations came in at 1315000000.0 for Q1 2026 at Abbott Laboratories, down from 3315000000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 3315000000.0 in Q4 2025 to a low of 1025000000.0 in Q1 2024.
• The 5-year median for Cash from Operations is 2065000000.0 (2022), against an average of 2134176470.59.
• Across the five-year window, Cash from Operations plunged 50.08% in 2023 and surged 62.93% in 2024, its largest moves.
• Abbott Laboratories' Cash from Operations stood at 2326000000.0 in 2022, then soared by 30.61% to 3038000000.0 in 2023, then declined by 5.6% to 2868000000.0 in 2024, then gained by 15.59% to 3315000000.0 in 2025, then slumped by 60.33% to 1315000000.0 in 2026.
• The last three Cash from Operations figures came in at 1315000000.0 (Q1 2026), 3315000000.0 (Q4 2025), and 2787000000.0 (Q3 2025), per Business Quant data.